News Release

Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide

JAMA Ophthalmology

Peer-Reviewed Publication

JAMA Network

About The Study: The findings of this study suggest an association between semaglutide, a glucagon-like peptide 1 receptor agonist, and nonarteritic anterior ischemic optic neuropathy. As this was an observational study, future study is required to assess causality. 

Corresponding Author: To contact the corresponding author, Joseph F. Rizzo III, M.D., email

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.